1. Home
  2. IPSC vs MRBK Comparison

IPSC vs MRBK Comparison

Compare IPSC & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$2.33

Market Cap

189.7M

Sector

Health Care

ML Signal

HOLD

Logo Meridian Corporation

MRBK

Meridian Corporation

HOLD

Current Price

$19.31

Market Cap

218.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
MRBK
Founded
2019
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
189.7M
218.1M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
IPSC
MRBK
Price
$2.33
$19.31
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$3.50
$20.00
AVG Volume (30 Days)
976.3K
90.9K
Earning Date
01-01-0001
04-30-2026
Dividend Yield
N/A
2.81%
EPS Growth
29.07
25.00
EPS
0.11
1.28
Revenue
$6,589,000.00
$5,735,000.00
Revenue This Year
$1,590.09
$25.40
Revenue Next Year
N/A
$8.15
P/E Ratio
$20.64
$15.61
Revenue Growth
194.81
16.38
52 Week Low
$0.34
$11.17
52 Week High
$2.71
$21.03

Technical Indicators

Market Signals
Indicator
IPSC
MRBK
Relative Strength Index (RSI) 62.07 49.78
Support Level $0.49 $14.00
Resistance Level $2.71 $20.86
Average True Range (ATR) 0.19 0.61
MACD 0.02 -0.16
Stochastic Oscillator 79.33 14.74

Price Performance

Historical Comparison
IPSC
MRBK

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About MRBK Meridian Corporation

Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.

Share on Social Networks: